New UAE oncology center treats over 3,000 cancer patients in its first year.

Photo-ZAWYA

Cleveland Clinic Abu Dhabi's Center, which is part of the M42 network, stands as a beacon of advanced cancer care in the UAE and the broader region. Established just over a year ago, this facility was inaugurated by none other than Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, the Crown Prince of Abu Dhabi. From its inception, the center has been dedicated to providing unparalleled personalized care to cancer patients, leveraging sophisticated technologies and a multidisciplinary approach.

Led by Dr. Stephen Grobmyer, the chair of the Oncology Institute, the center embodies a commitment to excellence in every aspect of cancer care. Their comprehensive approach covers the entire spectrum of cancer management, from screening and diagnosis to state-of-the-art treatment modalities like advanced radiation therapies and precision cellular interventions. The utilization of cutting-edge technologies such as generative AI, virtual reality, and augmented reality underscores their dedication to innovation in healthcare.

One of the cornerstones of the center's offerings is its integration of AI-driven solutions, which play a pivotal role in enhancing the accuracy and efficacy of interventions. Adaptive radiotherapy, for instance, utilizes AI and machine learning algorithms to dynamically adjust treatment plans in response to daily anatomical variations in patients, ensuring optimal outcomes throughout the course of treatment. This technology represents a significant advancement in precision medicine, allowing for personalized care tailored to each patient's unique needs.

Another groundbreaking intervention offered at the center is radioembolization, specifically Tare-Y90 therapy, a minimally invasive targeted treatment that utilizes radioactive particles to target and destroy cancer cells in the liver. This innovative approach not only improves patients' quality of life but also extends survival rates, offering hope to those battling this challenging disease.

In line with their commitment to staying at the forefront of medical innovation, the center recently introduced high-intensity focused ultrasound (HIFU) as a non-surgical alternative for prostate cancer patients. This revolutionary procedure offers a minimally invasive option for treatment, reflecting the center's dedication to providing cutting-edge care while prioritizing patient comfort and well-being.

Dr. Grobmyer emphasizes that the center's success is not just measured in medical achievements but also in the collaborative spirit that drives their efforts. Inspired by the visionary leadership of the UAE, the center places patients and their families at the heart of everything they do. As cancer continues to impact millions worldwide, their mission extends beyond fighting the disease to reshaping the future of medical care through continuous breakthroughs and advancements.

Within its first year of operation, the center has garnered global recognition from prestigious organizations such as the Joint Commission International (JCI), receiving a three-year accreditation—an affirmation of their unwavering commitment to excellence and quality in cancer care. As they look towards the future, Cleveland Clinic Abu Dhabi's Center remains steadfast in its dedication to pushing the boundaries of medical innovation and making a meaningful impact in the fight against cancer, one breakthrough at a time.

March 13, 2024 6:30 p.m. 12783

#CancerCareInnovation #CuttingEdgeHealthcare #MedicalBreakthroughs #PrecisionMedicine #FutureOfHealthcare #AIinMedicine #CancerResearch #PatientCenteredCare #HealthTechAdvancements #GlobalRecognition #breakingnews #worldnews #headlines #topstories #globalUpdate #dxbnewsnetwork #dxbnews #dxbdnn #dxbnewsnetworkdnn